ClariVest Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.29M | Hold |
14,469
| – | – | 0.23% | 118 |
|
|
2024
Q2 | $2.29M | Buy |
14,469
+39
| +0.3% | +$6.16K | 0.23% | 118 |
|
|
2024
Q1 | $1.87M | Sell |
14,430
-129
| -0.9% | -$16.7K | 0.19% | 154 |
|
|
2023
Q4 | $1.4M | Sell |
14,559
-12
| -0.1% | -$1.16K | 0.08% | 186 |
|
|
2023
Q3 | $1.77M | Buy |
14,571
+21
| +0.1% | +$2.55K | 0.1% | 135 |
|
|
2023
Q2 | $1.67M | Sell |
14,550
-3,004
| -17% | -$344K | 0.08% | 155 |
|
|
2023
Q1 | $2.42M | Sell |
17,554
-17
| -0.1% | -$2.34K | 0.11% | 152 |
|
|
2022
Q4 | $2.28M | Sell |
17,571
-69
| -0.4% | -$8.94K | 0.11% | 147 |
|
|
2022
Q3 | $1.95M | Buy |
+17,640
| New | +$1.95M | 0.09% | 167 |
|
|
2021
Q3 | – | Sell |
-10,700
| Closed | -$832K | – | 819 |
|
|
2021
Q2 | $832K | Hold |
10,700
| – | – | 0.03% | 330 |
|
|
2021
Q1 | $798K | Sell |
10,700
-100
| -0.9% | -$7.46K | 0.03% | 325 |
|
|
2020
Q4 | $1.84M | Sell |
10,800
-400
| -4% | -$68.2K | 0.06% | 221 |
|
|
2020
Q3 | $1.57M | Hold |
11,200
| – | – | 0.05% | 254 |
|
|
2020
Q2 | $1.8M | Buy |
+11,200
| New | +$1.8M | 0.05% | 245 |
|
|
2017
Q1 | – | Sell |
-13,931
| Closed | -$382K | – | 744 |
|
|
2016
Q4 | $382K | Buy |
+13,931
| New | +$382K | 0.01% | 427 |
|
|
2016
Q1 | – | Sell |
-23,717
| Closed | -$915K | – | 663 |
|
|
2015
Q4 | $915K | Buy |
+23,717
| New | +$915K | 0.03% | 294 |
|